Legislative note: The Treat and Reduce Obesity Act, reintroduced in Congress in 2025, would remove the Medicare exclusion for obesity medications
International researchers examined Swedish health records of almost 95,000 people with a diagnosis of depression or anxiety who were also taking various diabetes medications between 2009 and 2022
Photo by Innerbody Research The tablets arent massive, by any means, but they are substantial
Guidance for Industry: Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act
The survey included questions regarding drug brand, dosing regimen, time on treatment, efficacy (including pre-treatment weight and weight on treatment), and side effects, as well as reasons for pursuing or stopping GLP1 treatment
adults that examines Americans' evolving attitudes and behaviors toward GLP-1 medications